Pages that link to "Q73940408"
Jump to navigation
Jump to search
The following pages link to Platelet-derived growth factor-AA and -alpha receptor expression suggests an autocrine and/or paracrine loop in osteosarcoma (Q73940408):
Displaying 23 items.
- Dominant negative PDGF-C inhibits growth of Ewing family tumor cell lines (Q34130448) (← links)
- A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression (Q34224640) (← links)
- Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression (Q34640861) (← links)
- Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β. (Q34705278) (← links)
- Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors (Q35186715) (← links)
- Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy (Q35894540) (← links)
- Expression of c-kit in human osteosarcoma and its relevance as a prognostic marker (Q36017154) (← links)
- Molecularly targeted therapy for pediatric brain tumors (Q36272981) (← links)
- Characterization of the G-quadruplexes in the duplex nuclease hypersensitive element of the PDGF-A promoter and modulation of PDGF-A promoter activity by TMPyP4 (Q36360588) (← links)
- Specific tyrosine kinase inhibitors regulate human osteosarcoma cells in vitro (Q36803657) (← links)
- Primary intracranial soft tissue sarcomas in children, adolescents, and young adults: single institution experience and review of the literature (Q36924325) (← links)
- Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma (Q37109503) (← links)
- Targeted Therapy in Bone and Soft Tissue Sarcoma in Children and Adolescents (Q37981129) (← links)
- Current therapeutic strategies and novel approaches in osteosarcoma (Q38161735) (← links)
- PDGFs and PDGFRs in canine osteosarcoma: New targets for innovative therapeutic strategies in comparative oncology (Q39330425) (← links)
- Hypertrophic Osteoarthropathy Associated With Metastatic Phyllodes Tumor (Q39647970) (← links)
- Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors (Q39861042) (← links)
- VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis (Q39986326) (← links)
- Platelet derived growth factor (PDGF) contained in Platelet Rich Plasma (PRP) stimulates migration of osteoblasts by reorganizing actin cytoskeleton. (Q41285223) (← links)
- Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival (Q47143697) (← links)
- Potential role of CSF cytokine profiles in discriminating infectious from non-infectious CNS disorders (Q58091139) (← links)
- PDGF/PDGFR effects in osteosarcoma and the "add-on" strategy (Q58803894) (← links)
- Biology and therapy of malignant solid tumors in childhood (Q80510573) (← links)